Meng X - Search Results

1

Negative Correlation Between ¹⁸F-RGD Uptake via PET and Tumoral PD-L1 Expression in Non-Small Cell Lung Cancer.

Wu L, Liu J, Wang S, Bai M, Wu M, Gao Z, Li J, Yu J, Liu J, Meng X. Wu L, et al. Among authors: meng x. Front Endocrinol (Lausanne). 2022 Jun 30;13:913631. doi: 10.3389/fendo.2022.913631. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35846323 Free PMC article.

2

Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancer.

Yuan S, Meng X, Yu J, Mu D, Chao KS, Zhang J, Zhong W, Yu Y, Wang J, Sun X, Yang G, Wang Y. Yuan S, et al. Among authors: meng x. Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):727-34. doi: 10.1016/j.ijrobp.2006.08.057. Int J Radiat Oncol Biol Phys. 2007. PMID: 17293231

3

PET-based biodistribution and radiation dosimetry of epidermal growth factor receptor-selective tracer 11C-PD153035 in humans.

Liu N, Li M, Li X, Meng X, Yang G, Zhao S, Yang Y, Ma L, Fu Z, Yu J. Liu N, et al. Among authors: meng x. J Nucl Med. 2009 Feb;50(2):303-8. doi: 10.2967/jnumed.108.056556. Epub 2009 Jan 21. J Nucl Med. 2009. PMID: 19164239 Free article.

4

Prognostic value of serial [18F]fluorodeoxyglucose PET-CT uptake in stage III patients with non-small cell lung cancer treated by concurrent chemoradiotherapy.

Zhang HQ, Yu JM, Meng X, Yue JB, Feng R, Ma L. Zhang HQ, et al. Among authors: meng x. Eur J Radiol. 2011 Jan;77(1):92-6. doi: 10.1016/j.ejrad.2009.07.023. Epub 2009 Aug 19. Eur J Radiol. 2011. PMID: 19695804

5

Advances of radiation oncology in China.

Meng X, Yu JM. Meng X, et al. Chin Med J (Engl). 2009 Oct 5;122(19):2231-5. Chin Med J (Engl). 2009. PMID: 20079116 No abstract available.

6

[Principles and some related problems of target delineation in radiotherapy for esophageal cancer].

Meng X, Yu JM. Meng X, et al. Zhonghua Zhong Liu Za Zhi. 2009 Nov;31(11):801-3. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 20137341 Review. Chinese. No abstract available.

7

[Prognostic value of (18)F-fluorodeoxyglucose uptake in patients with non-small cell lung cancer treated by concurrent chemoradiotherapy].

Zhang HQ, Yu JM, Meng X, Yue JB, Feng R, Ma L. Zhang HQ, et al. Among authors: meng x. Zhonghua Zhong Liu Za Zhi. 2010 Aug;32(8):603-6. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21122413 Chinese.

8

Noninvasive evaluation of microscopic tumor extensions using standardized uptake value and metabolic tumor volume in non-small-cell lung cancer.

Meng X, Sun X, Mu D, Xing L, Ma L, Zhang B, Zhao S, Yang G, Kong FM, Yu J. Meng X, et al. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):960-6. doi: 10.1016/j.ijrobp.2010.10.064. Epub 2011 Mar 26. Int J Radiat Oncol Biol Phys. 2012. PMID: 21440998

9

Molecular imaging with 11C-PD153035 PET/CT predicts survival in non-small cell lung cancer treated with EGFR-TKI: a pilot study.

Meng X, Loo BW Jr, Ma L, Murphy JD, Sun X, Yu J. Meng X, et al. J Nucl Med. 2011 Oct;52(10):1573-9. doi: 10.2967/jnumed.111.092874. Epub 2011 Sep 8. J Nucl Med. 2011. PMID: 21903741 Free article.

10

Implementation of hypoxia measurement into lung cancer therapy.

Meng X, Kong FM, Yu J. Meng X, et al. Lung Cancer. 2012 Feb;75(2):146-50. doi: 10.1016/j.lungcan.2011.09.009. Epub 2011 Oct 15. Lung Cancer. 2012. PMID: 22001441 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,896 results

Search Page

Filters